Hematology & Oncology Doctors in Bellingham, WA Accepting Medicare

3 Hematology & Oncology doctors found. Showing 1 - 3

William D. Rubin, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3301 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-788-8222    Fax: 360-788-7759

Thomas Derleth, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4545 Cordata Pkwy, Bellingham, WA 98226 Phone: 360-738-2200

Dr. Brahma R Konda, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3301 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-788-8222    Fax: 360-788-7759

News Archive

Study offers potential ways to preserve muscle mass and strength for people in low-resistance environments

It is well known that muscles need resistance (gravity) to maintain optimal health, and when they do not have this resistance, they deteriorate. A new report published in the July 2015 issue of The FASEB Journal, however, suggests that this might not be true for all muscles, offering hope that there may be ways to preserve muscle mass and strength for individuals in low-resistance environments, whether it be the microgravity of space, extended periods in a hospital bed, or a 9-5 job behind a desk.

Myths and facts on labour disruption in nine community care access centres

On January 30, 2015, employees represented by the Ontario Nurses' Association (ONA) working in nine Community Care Access Centres (CCACs) went on strike. Ontario's CCACs believe that their patients, caregivers, health care partners, the general public and employees deserve a fact-based context for judging the relative merit of this labour disruption.

BioSante presents update on LibiGel clinical study at NAMS Annual Meeting

BioSante Pharmaceuticals, Inc. presented a LibiGel clinical study update at the 21st Annual Meeting of The North American Menopause Society (NAMS) on October 8, 2010, with more than 1,000 experts and practitioners in menopause and women's health in attendance.

Glide Pharma announces successful completion of pre-clinical proof-of-concept study with novel solid formulation of octreotide acetate

Glide Pharma, the pharmaceutical development and device company focused on solid dose formulations of therapeutics and vaccines, today announced that its novel solid formulation of octreotide acetate achieved successful results in a pre-clinical proof-of-concept study comparing it with the currently marketed liquid product (Sandostatin®).

Idenix Pharmaceuticals announces significant progress in HCV development programs

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced significant progress in three HCV programs

Read more Medical News

› Verified 7 days ago